Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
about
Anti-IL-12/23p40 antibodies for induction of remission in Crohn's diseaseHelminth therapy (worms) for induction of remission in inflammatory bowel diseaseHelminths for induction of remission in inflammatory bowel diseaseSargramostim (GM-CSF) for induction of remission in Crohn's diseaseSargramostim (GM-CSF) for induction of remission in Crohn's diseaseAnti-IL-12/23p40 antibodies for induction of remission in Crohn's diseaseEvidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanUse of the tumor necrosis factor-blockers for Crohn's diseaseEfficacy of early treatment with infliximab in pediatric Crohn's disease.Change in the treatment strategy for pediatric Crohn's diseaseChronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?The development and assessment of biological treatments for children.Infliximab to treat Crohn's disease: an update.In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells.Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease.Time of infliximab therapy initiation and dose escalation in Crohn's disease.Maintenance treatment with infliximab for the management of Crohn's disease in adults.Changes of the cytokine profile in inflammatory bowel diseases.Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis.Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery.TNFα causes thrombin-dependent vagal neuron apoptosis in inflammatory bowel disease.Evidence-based clinical practice guidelines for inflammatory bowel disease.Influence of nutritional status on the therapeutic effect of infliximab in patients with Crohn's disease.Psoriasis and inflammatory bowel disease: links and risks.The Role of Biological and Small Molecule Therapy in the Management of Psoriatic Arthritis.
P2860
Q24188040-55136427-7A6F-49F6-8B86-97369641420FQ24201067-48505A87-96A6-45FB-A980-16E84F14E03DQ24234013-8AACC478-A019-49A0-A034-72A9D1FBA10AQ24235068-164A58A8-3ABF-4798-B438-BC9AB0D68322Q24235115-5C77B793-E532-4EBC-91F5-8DE19602615CQ24240678-335AF9BC-88B1-4711-9CD8-BB3E9C323876Q26829392-080F5A5E-D5DA-4EE7-BE8F-539B1D111523Q27030762-CED886B9-E071-438B-B82F-DF63A230A278Q33782089-F9205F67-342A-476A-8E5E-1B4C6FA95274Q34420755-E05CD9C0-8FA2-4899-BA6D-157E5879A0FFQ34684222-B8CDA5E4-1FDF-40FA-91EA-BCF259404D61Q35135936-436B4515-C5BD-46F9-836E-ED6F2052499DQ35304737-3521DCD8-0552-48AC-8E35-EC2F84339F4EQ36063507-CAE3FD47-0444-4DA9-A922-8C97FB975D2BQ36094915-A7D63ED9-8450-4797-8BA2-4288FDA5BFD0Q36203845-27061EA9-DB87-47E9-8103-5026E204A57DQ36838066-1FA6A40C-0B0B-45D1-AB91-B06263AA2BF3Q37454462-8F7ABF6E-B988-47A2-A135-141476517E8DQ37586911-D6595813-8C3A-40D9-BDB1-F2BE976122CDQ38058782-1D0DA7B2-5DEE-4B7A-9DD9-D983A8896F78Q38850775-092CEF00-3994-40B7-A205-61FA0B30F3AEQ38888227-4117E6A2-A54A-4852-9920-8217225B6E2BQ39906629-CFB0B213-8A83-437F-956B-C6A804F8B442Q41807587-27930C9C-E322-4B46-82AF-58E89C137ECFQ50079201-0DF8D55D-CEE5-4726-8167-7D6668A4838DQ51697159-29DF57D0-3AE4-4E3C-A9E2-F65857D4DF8EQ52859380-C4FF9187-7081-4D35-9DD1-6E40C6596363Q55631301-2527B14E-DC04-47A7-9102-332CA560AEB5
P2860
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@ast
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en-gb
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@nl
type
label
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@ast
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en-gb
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@nl
prefLabel
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@ast
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en-gb
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@nl
P2860
P3181
P1476
Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease
@en
P2093
Anthony K Akobeng
Mary Zachos
P2860
P3181
P356
10.1002/14651858.CD003574.PUB2
P577
2003-10-20T00:00:00Z